Following CSD, the impairment of liver and metabolic functions was clearly demonstrated by the enhanced GOT, GPT, and ALP levels together with the incidences of hyperglycemia, hypertriglyceridemia, hyperlipidemia, and hyperinsulinemia (Fig. 7b). This evidence concerns the gene GPT and hyperlipidemia.